Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · IEX Real-Time Price · USD
3.365
+0.005 (0.15%)
At close: May 1, 2024, 4:00 PM
3.370
+0.005 (0.15%)
Pre-market: May 2, 2024, 4:13 AM EDT

Aquestive Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019201820172016
Market Capitalization
30313549156180146157--
Market Cap Growth
-176.07%-68.73%-13.14%23.41%-7.25%---
Enterprise Value
3912241442452381571442829
PE Ratio
-17.14-17.14-0.90-2.21-3.22-2.20-2.56--
PS Ratio
5.992.671.023.073.922.772.33--
PB Ratio
-1.27-1.27-0.41-1.90-3.71-23.8115.59--
P/FCF Ratio
-18.29-18.29-4.51-4.61-3.91-2.39-10.61--
P/OCF Ratio
-21.14-21.14-4.98-4.74-3.96-2.42-12.10--
EV/Sales Ratio
7.744.423.034.825.182.982.130.420.57
EV/EBITDA Ratio
331.17189.14-3.65-5.43-6.04-2.90-2.8510.9768.15
EV/EBIT Ratio
-1371.58-1371.58-3.44-5.09-5.55-2.75-2.68-22.76-8.51
EV/FCF Ratio
-30.31-30.31-13.31-7.23-5.17-2.58-9.707.49-3.22
Debt / Equity Ratio
-1.06-1.06-1.04-1.42-1.84-9.864.68-0.66-0.68
Debt / EBITDA Ratio
95.2495.24-3.10-2.59-2.28-1.12-0.9417.7489.47
Debt / FCF Ratio
-15.26-15.26-11.32-3.44-1.95-0.99-3.1912.12-4.22
Quick Ratio
1.771.770.811.831.843.372.041.531.85
Current Ratio
2.242.241.012.152.123.682.251.842.16
Asset Turnover
0.860.860.860.790.760.861.041.62-
Interest Coverage
-0.02-0.02-3.37-2.14-3.28-6.11-6.96-0.16-0.56
Return on Equity (ROE)
7.40%7.40%52.30%113.80%175.40%371.70%209.80%18.20%-
Return on Assets (ROA)
-13.40%-13.40%-98.10%-110.20%-92.50%-107.90%-94.40%-27.70%-
Return on Capital (ROIC)
-248.27%-248.27%-1003.24%-100.31%-104.73%-97.14%-85.43%0.49%5.10%
Earnings Yield
-2.60%-5.84%-111.37%-45.15%-31.01%-45.45%-39.06%--
FCF Yield
-2.44%-5.47%-22.19%-21.69%-25.56%-41.77%-9.43%--
Buyback Yield / Dilution
-25.69%-25.69%-27.99%-13.15%-32.71%-22.34%82.90%-2.06%-
Total Shareholder Return
-25.69%-25.69%-27.99%-13.15%-32.71%-22.34%82.90%-2.06%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).